Hear how an adaptive and evolving platform of proven and novel technologies enables biomanufacturers to successfully accomplish their bioprocessing goals through either intensified, connected or continuous bioprocessing.
Watch this video to learn the important decisions that each biopharma executive must make to break down roadblocks during the critical first step of cell line development and bring their molecule to clinic successfully.
Hear how an adaptive and evolving Platform of proven and novel technologies enable biomanufacturers to successfully accomplish their bioprocessing goals through either intensified, connected, or continuous bioprocessing.
This presentation describes a case study using Viresolve® Pro membrane filters where virus retention performance is characterized following process interruptions.
An overview of the regulatory requirements given in the latest guidance documents as well as a description of new technologies for determining the identity of cell substrates and virus seed stocks and detecting adventitious agent contamination.
Leaders address how next generation processing will have a significant impact on how therapies are brought to market, delivering them to patients faster and more cost-effectively than ever before.
Watch experts discuss best practices that can help you manage supply chain risks.
Rapid growth and geographic expansion in the biopharmaceutical market is increasing supply chain risks that need to be well understood.
Options for customizable single-use solutions that move as fast as the market does.
Discover how the unique, non-GMP environment and technical expertise available to you at the M Lab™ Collaboration Centers will propel you across the finish line of your drug development journey.
|
|
|
|
|
|
|
|
|